NEW YORK (GenomeWeb) – Exosome Diagnostics has raised about $1.5 million in private financing toward a targeted financing of $2.2 million, it said in a regulatory document filed on Monday. 

The raise is an extension of the Cambridge, Massachusetts-based molecular diagnostic firm's Series B round, which raised $27 million in March 2014, a spokesperson for the firm told GenomeWeb.